彭雅丽，女，1978年生，1996年考入生物化学专业，2000年获理学学士学位并免试推荐为生物化学与分子生物学专业硕博连读研究生（导师为王锐教授）。于2006年6月博士毕业后，在生物化学与分子生物学研究所从事神经肽构效关系，生理、药理学功能及其作用机制等方面的研究。相关的研究成果在SCI期刊上发表。目前主持科研基金项目2项，作为主要参与人参与2项。1. 多肽生物化学与药理化学2. 神经肽1. 主持甘肃省科技支撑项目（0708NKCA111），一种治疗阿尔茨海默病的新多肽药物的设计和活性研究，2008年1月-2010年12月，经费金额3万；2. 主持兰州市科技计划项目一项，新的胸腺肽α1生产工艺的研究，2008.1-2010.12，经费金额10万元。, Han RW,Chang M, Zhang L, Zhang RS, Li W, Han YF, Wang R. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor. Peptides. 2010;31(12):2259-63. (SCI, IF2010 = 2.654), Zhang JN, Chang M Li W, Han RW, Wang R. Effects of central neuropeptide S in the mouse formalin test. Peptides. 2010;31(10):1878-83. (SCI, IF2010 = 2.654)Chang M, Li W, , Gao YH, Yao J, Han RW, Wang R. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr]γ2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice. Brain Res. 2009;1271:36-48. (SCI, IF2010 = 3.393)Li W, Chang M, , Gao YH, Zhang JN, Han RW, Wang R. Neuropeptide S produces antinociceptive effect at the supraspinal level in mice. Regul. Pept. 2009;156:90-5. (SCI, IF2010 = 2.473)Han RW, Chang M, , Qiao LY, Yin XQ, Li W, Wang R. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice. Peptides. 2009;30(7): 1313-17. (SCI, IF2010 = 2.654)Han RW, Yin XQ, Chang M, ,Li W, Wang R. Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment in mice morris water maze. Neuro. Lett. 2009;455:74-7. (SCI, IF2010 = 2.055)Li W, Gao YH, Chang M, , Yao J, Han RW, Wang R. Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice. Peptides. 2009;30(2):234-40. (SCI, IF2010 = 2.654)Chen ZX, Chang M, , Zhao L, Zhan YR, Wang LJ, Wang R. Regulation of Endochondral Ossification by Osteogenic Growth Peptide C-terminal Pentapeptide [OGP(10-14)]. Protein Pept. Lett. 2009;16:1074-80. (SCI, IF2010 = 1.849)Li Z, Zhou LX, Zhang BH, Yan X, Li J, , Chang M, Dong SL,Wang R.Effect and mechanism of nociceptin/orphanin FQ reversing multi-drug resistance in K562/ADM cell.Pharmazie. 2008;63(9):676-85.(SCI, IF2010 = 0.893)Chen ZX, Chang M, , Zhao L, Zhan YR, Wang LJ, Wang R. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Regul Pept. 2007;142(1-2):16-23. (SCI, IF2010 = 2.473), Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R. Novel potent agonist [(pF)Phe,Aib,Aib,Arg,Lys]N/OFQ-NH2 and antagonist [Nphe,(pF)Phe, Aib,Aib,Arg,Lys]N/OFQ-NH2 of nociceptin/orphanin FQ receptor. Regul. Pept 2006;134:75-81. (SCI, IF2010 = 2.473)Fang Q, Guo J, , Chang M, He F, Chen Q, Wang R. In vitro and in vivo studies of dansylated compounds, the putative agonists and antagonists on neuropeptide FF receptors. Peptides2006;27:1297-304. (SCI, IF2010 = 2.654)Wang T, Li SR, Dai X, , Chen Q, Wang R. Effects of melatonin on orphanin FQ/nociceptin-induced hyperalgesia in mice.Brain Res.2006;1085(1):43-8.(SCI, IF2010 = 3.393)Yang Q, Chen Y, Fu C, Chang M, , Wang R.Effects of [Nphe1]nociceptin(1-13)NH2, [Phe1(CH2-NH)Gly2]nociceptin(1- 13)NH2, and nocistatin on nociceptin inhibited constrictions of guinea pig isolated bronchus.Protein Pept Lett. 2006;13(2):185-8.(SCI, IF2010 = 1.849)Fang Q, Guo J, He F, , Chang M, Wang R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 2006;27:2207-13. (SCI, IF2010 = 2.654)Chang M, , Dong SL, Han RW, Li W, Yang DJ, Chen Q, Wang R. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor. Regul. Pept 2005;130:116-22. (SCI, IF2010 = 2.473)主持项目：1、神经肽S与疼痛下行抑制通路关系的研究（30900445）。国家自然科学基金委。2、一种治疗阿尔茨海默病的新多肽药物的设计和活性研究（0708NKCA111）。甘肃省科技厅。3、新的胸腺肽α1生产工艺的研究（07-3-08）。兰州市科技局。参与项目：1、若干多肽合成和化学修饰的新方法研究及其在多肽药物产业开发中的应用（2009ZX09503）。科技部“重大新药创制”科技重大专项
。兰州大学兰州大学生命科学学院兰州大学生命科学学院 